Plunkett Research Online: AVEO Pharmaceuticals Inc

AVEO PHARMACEUTICALS INC (AVEO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company that seeks to advance targeted medicines for oncology and other unmet medical needs. AVEO’s lead candidate is tivozanib, which the firm is working to develop and commercialize in North America as a treatment for advanced or metastatic renal .....



AVEO Pharmaceuticals Inc
Ticker: AVEO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617 299-5000
Fax:
Address: One Broadway
14th Floor
Cambridge, MA 02142 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs (Pharmaceuticals), Discovery & Manufacturing
Contacts Description

Michael Bailey CEO/Director/President
Matthew Dallas CFO/Chief Accounting Officer
See More
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company that seeks to advance targeted medicines for oncology and other unmet medical needs. AVEO’s lead candidate is tivozanib, which the firm is working to develop and commercialize in North America as a treatment for advanced or metastatic renal .....See More See More

Auditor: EY
Legal Advisor: Wilmer Cutler Pickering Hale and Dorr LLP
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Tivozanib
FOTIVDA
Ficlatuzumab
AV-203
AV-380
AV-353
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: